Risk of antibody-mediated rejection in kidney transplant recipients with anti-HLA-C donor-specific antibodies
from American Journal of Transplantation (login required)
Anti-HLA donor-specific antibodies cause acute and chronic antibody-mediated rejection. However, the clinical relevance of anti-HLA-C antibodies remains unclear. We evaluated the clinical relevance of the presence of anti-HLA-C DSA at day 0 in renal transplant recipients. In this retrospective, case-controlled study, 608 patients who underwent kidney transplantation between August 2008 and March 2012 were screened for the presence of isolated anti-HLA-C DSA at day 0.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063